Reduction of hyaluronan and collagen production in the TME by inhibition of the rate-limiting enzyme glutamine-fructosamidyltransferase 1 (GFAT1) of HBP leads to extensive remodeling of the ECM and increased levels of CD8(+) T infiltration, while enhancing PD1 treatment responses, eventually resulting in tumour regression (249, 250)
Any inconsistency between public claims and investigational status may be interpreted as evidence of consumer deception or misbranding
If you are using Kojic Acid or Glutathione, keep your skincare routine simple
For people considering long-term GLP-1 use, the safety data is encouraging
Potential Causes of Allodynia Allodynia is associated with several neurological and metabolic conditions, including: Peripheral Neuropathy (due to diabetes, chemotherapy, or autoimmune disorders) Fibromyalgia (central pain sensitisation disorder) Migraine Disorders (involving trigeminal nerve hypersensitivity) Neuroinflammation and Immune Dysregulation (as seen in post-viral syndromes) Medication Side Effects, including possible links to GLP-1 receptor agonists Mechanisms: How GLP-1 Medications May Contribute to Allodynia GLP-1 receptor agonists (e.g., Mounjaro, Wegovy) are widely used for weight loss and glycemic control due to their role in glucose-dependent insulin secretion and appetite suppression